Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of IV Vinflunine in Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
2005-001463-64Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vinflunine in transitional cell carcinoma (TCC), sponsored by Bristol Myers Squibb. Primary endpoint: Objective response rate. Started Sep 2005; status: completed.
02
Drugs
vinflunine
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on 2005-001463-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001463-64.